On a per-share basis, the
The maker of instruments used in biomedical research posted revenue of
Bio-Rad shares have fallen 46% since the beginning of the year. In the final minutes of trading on Thursday, shares hit
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from
Copyright by Automated Insights, Inc. All rights reserved., source